Thomas Mertens (virologist)

Last updated
Thomas Mertens
Born (1950-03-10) 10 March 1950 (age 73)
Freiburg im Breisgau, Germany
NationalityGerman
Alma mater Cologne University
Occupation(s)Virologist
Chair, STIKO
Website https://www.rki.de/EN/Home/homepage_node.html

Thomas Michael Christian Mertens (born 10 March 1950 in Freiburg im Breisgau [1] ) is a German virologist [2] who currently heads the Standing Committee on Vaccination (STIKO), which as part of the Robert Koch Institute advises the German government regarding vaccines.

Contents

Career

From 1968 to 1976, Mertens first studied chemistry in Cologne and then medicine in Bonn, where he completed his dissertation (Dr. med.) under the supervision of de:Hans Joachim Eggers in 1976. He obtained his medical license (approbation) in 1977. [1] In 1984 he completed his habilitation in virology. From 1985 until 1991 he was professor at the Institute of Virology in Cologne, after which he moved to University of Ulm, heading the Institute of Virology at the University Clinic there from 1998. [3] In 2018 he retired from his position as professor of virology and medical director. [4] In his research, Mertens worked extensively on herpes viruses, in particular HCMV. [5]

In 2004, Mertens joined the Standing Committee on Vaccination (STIKO), and became its head in 2017. [5] In November 2023, the Federal Ministry of Health announced that a three-term limit would be applied to STIKO members, implying that Mertens would step down at the end of his term in February 2024. [6]

COVID-19 pandemic

During the COVID-19 pandemic in Germany, after vaccines became available in late 2020, STIKO and Mertens moved into the focus of politics, the wider public, and the media. [7] [8] Mertens repeatedly criticized what he said was pressure on STIKO from politics. [7] [9] [10] He himself was criticized for having allegedly confused the public on several occasions, and for having announced an upcoming STIKO recommendation for a booster shot for all adults in a talk show, rather than through standard channels, in November 2021. [8] [11]

In early December 2020, shortly before the rollout of the Pfizer–BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine in Germany, Mertens said that it would take over a year to vaccinate the whole population of Germany, due to capacity limits. [12] In September 2021, Mertens expressed dissatisfaction about vaccine hesitancy in Germany particularly in the age group between 18 and 59 years, stressing the importance of the vaccination rate of that group for the evolution of the fourth wave of the pandemic and beyond. [13]

In early December 2021, Mertens stated in a podcast by Frankfurter Allgemeine Zeitung that if he had a seven- to eight-year old child, he would "probably" refrain from having it vaccinated against the coronavirus at that time; soon after, in a 10 December interview with Die Welt , he however stated that he regretted having said anything personal at all, that any suspicions that he himself was a vaccination sceptic were "complete nonsense", and that he had never opposed vaccination. His previous comment had been taken out of context and had been completely correct and comprehensible, he said. At the time of the Die Welt interview, the STIKO had only recommended vaccination to those children between five and eleven years of age which belonged to risk groups, while also opening it to other children of that age group on the condition that parents had a discussion with a doctor. [14] In May 2022, the RKI updated its vaccine recommendations to include a single shot of an mRNA vaccine for healthy children from the age of five years for the Pfizer–BioNTech vaccine, and from six years for Moderna. [15]

Mertens became an inaugural member of the Corona-Expertenrat (corona advisory panel) established by the Scholz cabinet in December 2021. [16]

In January 2022, Mertens said that he opposed a COVID-19 general vaccine mandate for all aged 18 and over, as this would "divide society". He also expressed doubt about whether such a measure would actually be effective, as even the threat of a fine would possibly not change the minds of those who did not want to be vaccinated. He also opined that the severe COVID-19 wave at that time could not be reined in by a general mandate. [17] In April 2022, he welcomed that the push for a general vaccine mandate had been abandoned in the Bundestag parliament, saying that the "main reason" for such a mandate, namely stemming the spread of the virus, could at present not be achieved through vaccination; and that it was "more sensible to limit the vaccine mandate to vulnerable groups". [18]

In an interview published in November 2023, Mertens said he saw "no real mistakes" in the work of STIKO during the pandemic; criticism directed at the commission had often been "simply wrong". Many decisions, however, had to be made speedily and with limited knowledge. [19]

Personal life

Mertens has four children of adult age. His hobby is playing the clarinet. [7]

Books (as editor)

Related Research Articles

<span class="mw-page-title-main">Wolfgang Kubicki</span> German politician (FDP), Vice-President of the Bundestag

Wolfgang Kubicki is a German politician of the Free Democratic Party of Germany (FDP) and member of the Bundestag from 1990 until 1992 and 2017 onwards. He has been vice chairman of the FDP in Germany since December 2013. Since 24 October 2017 he has served as Vice President of the Bundestag. From 1992 to 1993 and from 1996 to 2017 he served as chairman of the FDP-group in the Schleswig-Holstein state parliament.

The Standing Committee on Vaccination at the Robert Koch Institute, or STIKO, is a scientific committee comprising 18 members at the Robert Koch Institute in Berlin, Germany that provides official recommendations for the vaccination schedules used by the individual German states. The committee meets twice yearly to review the latest research regarding vaccination against infectious diseases. Although the STIKO makes recommendations, immunization in Germany is voluntary and there are no official government recommendations. German Federal States typically follow the STIKO's recommendations minimally, although each state can make recommendations for their geographic jurisdiction that extends beyond the recommended list. In addition to the proposed immunization schedule for children and adults, the STIKO recommends vaccinations for occupational groups, police, travelers, and other at risk groups.

<span class="mw-page-title-main">COVID-19 pandemic in Germany</span> Ongoing COVID-19 viral pandemic in Germany

The COVID-19 pandemic in Germany has resulted in 38,437,756 confirmed cases of COVID-19 and 174,979 deaths.

<span class="mw-page-title-main">Christian Drosten</span> German virologist researching emergent viruses

Christian Heinrich Maria Drosten is a German virologist whose research focus is on novel viruses (emergent viruses). During the COVID-19 pandemic, Drosten came to national prominence as an expert on the implications and actions required to combat the illness in Germany.

<span class="mw-page-title-main">Andrew Ullmann</span> German politician

Andrew John Ullmann is a German physician and politician of the Free Democratic Party (FDP) who has been serving as a member of the Bundestag from the state of Bavaria since 2017.

<span class="mw-page-title-main">Uğur Şahin</span> German oncologist and immunologist (born 1965)

Uğur Şahin is a German oncologist and immunologist. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields of research are cancer research and immunology.

<span class="mw-page-title-main">COVID-19 vaccination in Switzerland</span> Plan to immunize against COVID-19

COVID-19 vaccination in Switzerland is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">EpiVacCorona</span> EpiVacCorona vaccine against COVID-19

EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase III clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The conclusions and results of the trial have not been made public.

<span class="mw-page-title-main">COVID-19 vaccination in South Africa</span> Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in New Zealand</span> Ongoing COVID-19 vaccine programme in New Zealand

COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Germany</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Germany began on 26 December 2020.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

<span class="mw-page-title-main">COVID-19 vaccination in Ukraine</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

<span class="mw-page-title-main">COVID-19 vaccine hesitancy in the United States</span> Reluctance by those living in the USA to be vaccinated with a COVID-19 vaccine

COVID-19 vaccine hesitancy in the United States is the sociocultural phenomenon of individuals refusing or displaying hesitance towards receiving the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy.

<span class="mw-page-title-main">COVID-19 vaccine misinformation and hesitancy</span> Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it

Anti-vaccination activists and other people in many countries have spread a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines based on misunderstood or misrepresented science, religion, and law. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines are made, a story about COVID-19 being spread by 5G, and other false or distorted information. This misinformation has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize or coerce vaccination, such as lotteries, mandates, and free entry to events, which has in turn led to further misinformation about the legality and effect of these measures themselves.

<span class="mw-page-title-main">COVID-19 vaccination mandates in the United States</span> Mandates for people to receive the COVID-19 vaccine in the U.S.

Over the course of the COVID-19 pandemic, COVID-19 vaccine mandates have been enacted by numerous states and municipalities in the United States, and also by private entities. In September 2021, President Joe Biden announced that the federal government would take steps to mandate COVID-19 vaccination for certain entities under the authority of the federal government or federal agencies. Most federal mandates thus imposed were either overturned through litigation, or withdrawn by the administration, although a mandate on health care workers in institutions receiving Medicare and Medicaid funds was upheld. All federal mandates were lifted when the national emergency was declared to have ended in May 2023. A small number of states have gone in the opposite direction, through executive orders or legislation designed to limit vaccination mandates.

<span class="mw-page-title-main">Vaccine passports during the COVID-19 pandemic</span> Use of immunity passports for COVID-19 vaccination

A vaccine passport or proof of vaccination is an immunity passport employed as a credential in countries and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health authority, and usually consists of a digital or printed record. Some credentials may include a scannable QR code, which can also be provisioned via mobile app. It may or may not use a COVID-19 vaccine card as a basis of authentication.

<span class="mw-page-title-main">German government response to the COVID-19 pandemic</span> Actions by the German government on COVID-19 pandemic

The government of Germany has initially responded to the COVID-19 pandemic in the country with preventive measures to curb the spread of the coronavirus disease 2019 in the country. With the nationwide spread of the disease from March 2020, preventive measures were replaced by containment measures, including a lockdown from March. On 25 March, the Bundestag made the determination of an epidemic situation of national significance. This created a legal framework for the government of chancellor Angela Merkel and the heads of the 16 German states to agree on nationwide pandemic restrictions. Implementation of decisions by that panel remained a matter of individual states, however, leading to differences in anti-pandemic rules and regulations across states.

The 2022–2023 mpox outbreak in Germany is part of an ongoing global outbreak of human mpox caused by the West African clade of the monkeypox virus. At the beginning of September 2022, Spain, France, Germany and the United Kingdom are the countries with most cumulative cases in Europe.

References

  1. 1 2 "Prof. Thomas Mertens". www.bundesregierung.de (in German). n.d. Retrieved 18 August 2022.
  2. ↑ "Germany: Top vaccine advisory body STIKO holds off endorsing vaccine for teens". Deutsche Welle . 3 August 2021. Retrieved 18 August 2022.
  3. ↑ ""Fake News halten sich im Internet hartnäckig" (Interview with Wolfgang Geissel)". Ärzte-Zeitung (in German). 13 April 2017. Retrieved 19 August 2022.
  4. ↑ Geinitz, Christian (17 November 2021). "Ruhepol der Wissenschaft". FAZ (in German). Retrieved 18 August 2022.
  5. 1 2 Spielberg, Petra (31 March 2017). "Thomas Mertens: Virologe ist neuer Leiter der STIKO". Deutsches Ärzteblatt (in German). Retrieved 18 August 2022.
  6. ↑ "Stiko wird personell neu aufgestellt – Chef Mertens hört auf". Der Spiegel (in German). 23 November 2023. Retrieved 23 November 2023.
  7. 1 2 3 "Dieser Ruheständler entscheidet, wie Deutschland gegen Corona impft". Wirtschaftswoche (in German). 4 July 2021. Retrieved 18 August 2022.
  8. 1 2 Peduto, Alessandro (20 December 2021). "Wie der Stiko-Chef bei Corona-Impfungen für Verwirrung sorgt". Berliner Morgenpost (in German). Retrieved 18 August 2022.
  9. ↑ "CSU-Landesgruppenchef Dobrindt: "Große Schwachstelle", dass es kein Impfangebot für Jüngere gibt (Interview with Katharina Hamberger)". Deutschlandfunk (in German). 11 July 2021. Retrieved 19 August 2022.
  10. ↑ "Stiko-Chef Mertens: Druck wegen Kinderimpfung ist "absurd"". FAZ (in German). 30 September 2021. Retrieved 19 August 2022.
  11. ↑ Hairapetian, Marc (17 November 2021). "Markus Lanz (ZDF): Stiko-Chef lässt beim Corona-Talk die Booster-Bombe platzen". Frankfurter Rundschau (in German). Retrieved 20 August 2022.
  12. ↑ "COVID vaccinations in Germany will take over a year - expert panel head". Reuters . 2 December 2020. Retrieved 18 August 2022.
  13. ↑ "Stiko-Chef Mertens: "Wir müssen die Impfunwilligen überzeugen!"". BR (in German). 25 September 2021. Retrieved 18 August 2022.
  14. ↑ "Stiko-Chef Mertens bedauert persönliche Aussage zur Kinderimpfung". Der Spiegel (in German). 10 December 2021. Retrieved 19 August 2022.
  15. ↑ "Pressemitteilung der STIKO zur COVID-19-Impfempfehlung für Kinder von 5-11 Jahren und für Personen mit durchgemachter SARS-CoV-2-Infektion und bisher unvollständiger Immunisierung (20. Aktualisierung)". RKI (in German). 24 May 2022. Retrieved 19 August 2022.
  16. ↑ "Expertenrat für Vorbereitung weiterer Corona-Schutzmaßnahmen". Deutschlandfunk (in German). 23 January 2022. Retrieved 18 August 2022.
  17. ↑ "Stiko-Chef Mertens lehnt allgemeine Corona-Impfpflicht ab". Die Welt (in German). 13 January 2022. Retrieved 19 August 2022.
  18. ↑ "Stiko-Chef Mertens begrüßt Aus für Impfpflicht ab 18". Stuttgarter Nachrichten (in German). 5 April 2022. Retrieved 22 April 2022.
  19. ↑ "Virologe Mertens: "Ich könnte alle diese Impfempfehlungen auch heute noch unterschreiben"". Ärzte-Zeitung (in German). 23 November 2023. Retrieved 23 November 2023.

"Prof. Dr. Thomas Mertens". Robert Koch Institute (in German). n.d. Retrieved 19 August 2022.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.